Alkyl Amines Chemicals (506767) Q4 24/25 earnings summary

Executive summary

• Modest top-line growth for the year, with significant volume growth offset by price declines; raw material prices also decreased, supporting margins.

• Major projects, including a new plant at Dahej, are progressing as planned, with mechanical completion expected by December or January and impact anticipated in the next financial year.

• Capacity utilization averaged 60-70% across plants, with some plants reaching up to 85%.

• Audited financial results for the year ended March 31, 2025, were approved by the Board on May 9, 2025.

• Business operates in a single segment: Specialty Chemicals.

Financial highlights

• Revenue from operations for FY25 was ₹1,571.82 crore, up from ₹1,440.61 crore year-over-year.

• Net profit after tax for FY25 was ₹186.11 crore, compared to ₹148.87 crore in FY24.

• EBITDA margin stabilized at 21% for the year, up from 19% last year.

• Volume growth for the quarter was 4-5% sequentially and 15% year-over-year; full-year volume growth was around 13%.

• Earnings per share (basic) for FY25 stood at ₹36.40, up from ₹29.13 in FY24.

Outlook and guidance

• Double-digit volume growth (10-15%) expected for the next year, though pricing pressure is likely to persist.

• Board recommended a final dividend of ₹10 per equity share (500%), subject to shareholder approval.

• EBITDA margins are expected to remain around 20-21%, with no immediate improvement anticipated due to ongoing price pressure.

• Management remains cautiously optimistic, citing strong underlying demand and growth opportunities in India.

• Methylamines and ethylamines are expected to remain under pressure due to oversupply; acetonitrile prices may improve if anti-dumping duties are implemented.